A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
Clinical trial NCT02637193 · COMPLETED
Trial details
- NCT number
- NCT02637193
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.